Quanterix Q4 Revenues Down 15 Percent
The company posted revenues of $25.8 million for the quarter, down from $30.3 million in Q4 2021 and in line with the consensus Wall Street estimate.
People in the News at Quanterix, Arima Genomics, Theralink, Vizgen, DNAnexus, More
Executive appointments, promotions, and departures in omics and molecular diagnostics for the week of Jan. 9, 2023.
JP Morgan Healthcare Conference, Day 4: Singular Genomics, Quantum-Si, Quanterix
On the last day of the conference, Singular Genomics and Quantum-Si provided updates on their recently launched systems while Quanterix addressed its ongoing restructuring.
GenomeWeb Top 40 Down 3 Percent in December, Though More Resilient Than Broader Market
The Dow Jones Industrial Average was down 4 percent, while the Nasdaq fell 9 percent, and the Nasdaq Biotech Index was down 3 percent.
For proteomics firms, 2022 marked a reversal from an earlier boom, but the field pushed into emerging areas like single-cell, single-molecule, and spatial analyses.